High-Throughput Measurement of Physicochemical Properties

Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability

Volumn 40, Issue , 2009, Pages 101-132

  Mason, Barbara P ^a  

^a NONE

Author keywords

Lipophiliity; Log D; Log P; PAMPA; Permeability; Physicochemical measurements; PKa; Solubility

Indexed keywords

SOLUBILITY;

HIGH-THROUGHPUT MEASUREMENTS; LIPOPHILIITY; PAMPA; PHYSICO-CHEMICAL MEASUREMENTS; PHYSICOCHEMICAL PROPERTY;

MECHANICAL PERMEABILITY;

EID: 84879568933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527623860.ch6     Document Type: Chapter

References (77)

1. Hill, A. High-throughput solubility, http://www.physchem.org.uk/symp03/symp03_ah.pdf.
2. Kerns, E.H. (2001) High-throughput physicochemical profiling for drug discovery. Journal of Pharmaceutical Sciences, 90, 1838-1858.
3. Goodwin, J.J. (2006) Rationale and benefit of using high-throughput solubility screens in drug discovery. Drug Discovery Today: Technologies, 3 (1), 67-71.
4. Taub, M.E., Kristensen, L. and Frokjaer, S. (2002) Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. European Journal of Pharmaceutical Sciences, 15, 331-340.
5. Bevan, C.D. (2000) A high-throughput screening method forthe determination of aqueous drug solubility using laser nephelometry in microtiter plates. Analytical Chemistry, 72, 1781-1787.
6. Dehring, K.A., Workman, H.L., Miller, K.D., Mandagere, A. and Poole, S.K. (2004) Automated robotic liquid handling/laser-based nephelometry system for high-throughput measurement of kinetic aqueous solubility. Journal of Pharmaceutical and Biomedical Analysis, 36, 447-456.
7. Fligge, T.A. and Schuler, A. (2006) Integration ofa rapid automated solubility classification into early validation of hits obtained by high-throughput screening. Journal of Pharmaceutical and Biomedical Analysis, 42, 449-454.
8. Llinas, A., Box, K.J., Burley, J.C., Glen, R.C. and Goodman, J.M. (2007) A new method for the reproducible generation of polymorphs: two forms of sulindac with very different solubilities. Journal of Applied Crystallography, 40 (2), 379-381.
9. Seadeek, C., Ando, H., Bhattachar, S.N., Heimbach, T., Sonnenberg, J.L. and Blackburn, A.C. (2007) Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds. Journal of Pharmaceutical and Biomedical Analysis, 43, 1660-1666.
10. Sugano, K., Kato, T., Keiko, K., Sujaku, T. and Mano, T. (2006) High-throughput solubility measurement with automated polarized light microscopy analysis. Journal of Pharmaceutical Sciences, 95 (10), 2115-2122.
11. Avdeef, A. (1992) Quantitative Structure-Activity Relationships, 11, 510-517.
12. Comer, J. (2006) Ionisation constants and ionisation profiles, in Comprehensive Medicinal Chemistry (eds D.J. Triggle and J.B. Taylor), Elsevier, Oxford, pp. 357-397.
13. Avdeef, A. (1983) Weighting scheme for regression analysis using pH data from acid base titrations. Analytica Chimica Acta, 148, 237-244.
14. Avdeef, A. (1993) pH-metric log P II. Refinement of partition coefficients and ionisation constants of multiprotic substances. Journal of Pharmaceutical Sciences, 82, 183-190.
15. Tam, K.Y. and Takács-Novák, K. (2001) Multiwavelength spectrophotometric determination of acid dissociation constants: a validation study. Analytica Chimica Acta, 434, 157-167.
16. Allen, R.I., Box, K.J., Comer, J.E.A., Peake, C. and Tam, K.Y. (1998) Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs. Journal of Pharmaceutical and Biomedical Analysis, 17, 699-712.
17. a values in a mixed-buffer linear pH gradient system. Analytical Chemistry, 75, 883-892.
18. a determination of water-insoluble substances. Analytical Chemistry, 65, 42-49.
19. a determination of water-insoluble compounds: validation study in methanol/water mixtures. International Journal ofPharmaceutics, 151, 235-324.
20. a determination of water-insoluble compounds: validation study in a new cosolvent system. Analytica Chimica Acta, 583, 418-428.
21. Hardcastle, J.E. and Jano, I. (1998) Determination ofdissociation constants of polyprotic acids from chromatographic data. Journal ofChromatography B, 717, 39-56.
22. Canals, I., Portal, J.A., Bosch, E. and Rosés, M. (2000) Retention of ionizable compounds on HPLC.4. Mobile phase pH measurement in methanol/water. Analytical Chemistry, 72, 1802-1809.
23. Espinosa, S., Bosch, E. and Rosés, M. (2000) Retention of ionizable compounds on HPLC. 5. pH scales and the retention of acids and bases with acetonitrile-water. Analytical Chemistry, 72, 5193-5200.
24. Gluck, S.J., Steele, K.P. and Benko, M.H. (1996) Determination of acidity constants of monoprotic and diprotic acids by capillary electrophoresis. Journal of Chromatography A, 745, 117-125.
25. Ishihama, Y., Oda, Y. and Asakawa, N. (1994) Microscale determination of dissociation constants of multivalent pharmaceuticals by capillary electrophoresis. Journal of Pharmaceutical Sciences, 83, 1500-1507.
26. a values of zwitterionic drugs in acetonitrile-water mixtures. Analytica ChimicaActa, 437, 309-321.
27. Poole, S.K., Patel, S., Dehring, K., Workman, H. and Poole, C.F. (2004) A determination of acid dissociation constants by capillary electrophoresis. Journal of Chromatography, 1037, 445-454.
28. www.combisep.com/systems/pKa_technology.html.
29. a values of newly synthesized heteroarylaminoethanols by CZE. European Journal of Pharmaceutical Sciences, 30, 375-379.
30. a values ofpharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection. Journal of Chromatography A, 979, 369-437.
31. a values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry. Rapid Communications in Mass Spectrometry, 17, 2639-3264.
32. Camenisch, G., Folkers, G. and van de Waterbeemd, H. (1996) Review of theoretical passive drug absorption models: historical background, recent developments and limitations. Pharmaceutica Acta Helvetiae, 5, 309-327.
33. Hansch, C. and Leo, A. (1993) MedChem Database, Medicinal Chemistry Project, Pomona, CA.
34. oct from structures. Chemical Reviews, 93, 1281-1306.
35. Leo, A.J., Hansch, C. and Elkins, D. (1971) Partition coefficients and their uses. Chemical Reviews, 71, 525-616.
36. Hansch, C. and Fujita, T. (1964) ρ-σ-π Analysis. A method for the correlation of biological activity and chemical structure. Journal ofthe American Chemical Society, 86, 1616-1625.
37. Franks, N.P., Abraham, M.H. and Lieb, W.R. (1993) Molecular organization of liquid n-octanol: an X-ray diffraction analysis. Journal ofPharmaceutical Sciences, 82, 466-470.
38. Avdeef, A. (1993) pH-metric log P. II. Refinement of partition coefficients and ionization constants of multiprotic substances. Journal of Pharmaceutical Sciences, 82, 183-190.
39. Slater, B., McCormack, A., Avdeef, A. and Comer, J.E.A. (1994) pH-metric log P. 4. Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values. Journal of Pharmaceutical Sciences, 83 (9), 1280-1283.
40. Caron, G., Gaillard, P., Carrupt, P.-A. and Testa, B. (1997) Lipophilicity behaviour of model and medicinal compounds containing a sulfide, sulfoxide or sulfone moiety. Helvetica Chimica Acta, 80, 449-462.
41. Takács-Novák, K. and Avdeef, A. (1996) Interlaboratory study of log P determination by shake-flask and potentiometric methods. Journal of Pharmaceutical and Biomedical Analysis, 14, 1405-1413.
42. Gocan, S., Cimpan, G. and Comer, J. (2006) Lipophilicity measurements by liquid chromatography. Advances in Chromatography, 44, 79-176.
43. Pehourcq, F., Jarry, C. and Bannwarth, B. (2003) Potential of immobilized artificial membrane chromatography for lipophilicity determination of arylpropionic acid non-steroidal antiinflammatory drugs. Journal of Pharmaceutical and Biomedical Analysis, 33, 137-144.
44. Giaginis, C., Theocharis, S. and Tsantili-Kakoulidou, A. (2007) Octanol/water partitioning simulation by reversed-phase high performance liquid chromatography for structurally divers acidic drugs: effect of n-octanol as mobile phase additive. Journal of Chromatography A, 1166, 116-125.
45. Balogh, G.T., Zoltan, S., Forrai, E., Gyorffy, W. and Lopata, A. (2005) Use of reversed-phase liquid chromatography for determining the lipophilicity of a-aryl-n-cyclopropylnitrones. Journal of Pharmaceutical and Biomedical Analysis, 39, 1057-1062.
46. Darrouzin, F., Dallet, P., Dubost, J.-P., Ismaili, L., Pehourcq, F., Bannwarth, B., Matoa, M. and Guillaume, Y.C. (2006) Molecular lipophilicity determination of a huperzine series by HPLC: comparison of C18 and IAM stationary phases. Journal of Pharmaceutical and Biomedical Analysis, 41, 228-232.
47. Plass, M., Valkó, K. and Abraham, M.H. (1998) Determinationof solute descriptors of tripeptide derivatives based on high-throughput gradient high-performance liquid chromatography retention data. Journal of Chromatography A, 803, 51-60.
48. Valkó, K. (2004) Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution. Journal of Chromatography A, 1037, 299-310.
49. Valkó, K., Bevan, C. and Reynolds, D. (1997) Chromatographic hydrophobicity index by fast-gradient RP-HPLC: a high-throughput alternative to log P/log D. Analytical Chemistry, 69, 2022-2029.
50. alkane using polystyrene divinylbenzene and immobilised artificial membrane stationary phases in reversed-phase high-performance liquid chromatography. Journal ofChromatography A, 766, 35-47.
51. Sekine, T., Watanabe, T., Hosoyamada, M., Kanai, Y. and Endon, H. (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. The Journal of Biological Chemistry, 272, 18526-18529.
52. Ueda, K., Cornwell, M.M., Gottesman, M.M., Pastan, I., Roninson, I.B., Ling, V. and Riordan, J.R. (1986) The MDR1 gene, responsible for multi-drug resistance, codes for P-glycoprotein. Biochemical and Biophysical Research Communications, 141, 956-962.
53. Krishaa, G., Chen, K., Lin, C. and Nomeir, A.A. (2001) Permeability of lipophilic compounds in drug discovery using in vitro human absorption model, Caco-2. International Journal ofPharmaceutics, 222, 77-89.
54. Faassen, F., Vogel, G., Sapnings, H. and Vromans, H. (2003) Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. International Journal ofPharmaceutics, 263, 113-122.
55. Fisher, H., Gottschlich, R. and Seelig, A. (1998) Blood-brain barrier permeation: molecular parameters governing passive diffusion. The Journal ofMembrane Biology, 165, 201-211.
56. Kansy, M., Senner, F. and Gubernator, K. (1998) Physicochemical high-throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. Journal of Medicinal Chemistry, 41, 1007-1010.
57. Box, K., Comer, J. and Hague, F. (2006) Pharmaceutical Profiling in Drug Research (eds B. Testa and S. Krämer), Wiley-VCH Verlag GmbH, Weinheim, pp. 243-257.
58. Faller, B., Grimm, H.P., Loeuilet-Ritzler, F., Arnold, S. and Briand, X. (2005) High-throughput lipophilicity measurement with immobilized artificial membranes. Journal of Medicinal Chemistry, 48, 2571-2576.
59. Chen, Z. and Weber, S.G. (2007) High-throughput method for lipophilicty measurement. Analytical Chemistry, 79, 1043-1049.
60. Bellman, K., Decker, C.J., Jiang, Li., Li, Y., Liu, Z., Sanders, V., Shokri, A., Steel, M. and Worley, J. (2007) AAPS, November.
61. Lundahl, P. and Beigi, F. (1997) Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions. Advanced Drug Delivery Reviews, 23, 221-227.
62. Yang, C.Y., Cai, S.J., Liu, H. and Pidgeon, C. (1997) Immobilized artificial membranes: screens for drug-membrane interactions. Advanced Drug Delivery Reviews, 23, 229-256.
63. Stenberg, P., Luthman, P. and Artursson, P. (2000) Virtual screening of intestinal drug permeability. Journal ofControlled Release, 65, 231-243.
64. Palm, K., Luthman, K., Ungell, A-L., Strandlund, G., Beigi, F., Lundahl, P. and Artursson, P. (1998) Evaluationofdynamic polar molecular surface areaas predictor of drug absorption: comparison with other computational and experimental predictors. Journal ofMedicinal Chemistry, 41, 5382-5392.
65. Zhue, C., Jiang, L., Chen, T.-M. and Hwang, K.-K. (2002) A comparative study of artificial membrane permeability assay for high-throughput profiling of drug absorption potential. European Journal of Medicinal Chemistry, 37, 399-407.
66. http://www.bdbiosciences.com/nvCategory.jsp?modeCategory=FULL.
67. Sugano, K., Hamada, H., Machida, M. and Ushio, H. (2001) High-throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay. Journal of Biomolecular Screening, 6, 189-196.
68. Sugano, K., Hamada, H., Machida, M., Ushio, H., Saitoh, K. and Terrada, K. (2001) Optimized conditions of bio-mimetic artificial membrane permeability assay. International Journal ofPharmaceutics, 228, 181-188.
69. Di, L., Kerns, E., Fan, K., McConnel, O.J. and Carter, G.I. (2003) High-throughput artificial membrane permeability assay for blood-brain barrier. European Journal ofMedicinal Chemistry, 38, 223-232.
70. Youdim, K.A., Avdeef, A. and Abbott, N.J. (2003) In vitro trans-monolayer permeability calculations: often forgotten assumptions. Drug Discovery Today, 8 (21), 997-1003.
71. Avdeef, A. (2003) Absorption and Drug Development: Solubility, Permeability and Charged State, John Wiley & Sons, Ltd, Chichester, pp. 139-145.
72. Lennernas, H. (1998) Human intestinal permeability. Journal of Pharmaceutical Sciences, 87, 403-410.
73. Suomalainen, P., Johnas, C., Soaderlund, T. and Kinnunen, P.K.J. (2004) Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. Journal ofMedicinal Chemistry, 47 (7), 1783-1788.
74. Onishi, Y., Hirano, H., Nikata, K., Oosumi, K., Nagakura, M., Tarui, S. and Ishikawa, T. (2003) Chem-Bio Interface Journal, 3 (4), 175-193.
75. Seelig, A., Gottschlich, R. and Devant, P.M. (1994) A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America, 91, 6-72.
76. Fisher, H., Seelig,A., Chou, R.C. and van de Waterbeemd, H. (1997) The difference between the diffusion through the blood-brain barrier and the gastrointestinal membrane. 4th International Conference on Drug Absorption, Edinburgh.
77. Freeman, E. PhysChem measurements: more than just a number, http://www.physchem.org.uk/symp03/symp03_ef.pdf.